George Jean 4
4 · Cyteir Therapeutics, Inc. · Filed Feb 16, 2024
Insider Transaction Report
Form 4
George Jean
Director
Transactions
- Exercise/Conversion
Common Stock
2024-02-14$1.69/sh+14,150$23,914→ 14,150 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-14−14,150→ 0 totalExercise: $1.69From: 2024-02-03Exp: 2033-02-03→ Common Stock (14,150 underlying)
Holdings
- 2,444,265(indirect: See Footnote)
Common Stock
Footnotes (1)
- [F1]Shares held by Lightstone Ventures II, L.P. and Lightstone Ventures II (A), L.P. LSV Associates II, LLC is the general partner of Lightstone Ventures II, L.P. and Lightstone Ventures II (A), L.P. The Reporting Person is a managing director of LSV Associates II, LLC. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of her pecuniary interest therein.